Clinical Trials · NCT01400516
Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 26
- Start date
- Aug 2011
- Locations
- 3 sites, United States
- Primary endpoint
- Change From Baseline in Joint Erosion Volume Measured by 3-Dimensional Computed Tomography (3D CT) Scan